Skip to Content
ToxicsToxics
  • Article
  • Open Access

22 August 2026

23 Pages

Curcumin Opposes Perfluorodecanoic Acid–Induced Adipogenesis Through the PPARγ/C/EBPα Axis in 3T3-L1 Cells

,
and
1
Institute of Health Sciences, Department of Molecular Medicine, Dokuz Eylül University, 35340 İzmir, Türkiye
2
Faculty of Health Sciences, Department of Nutrition and Dietetics, Aydın Adnan Menderes University, 09010 Aydın, Türkiye
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.

Highlights

What are the main findings?
At the mRNA level, PFDA mainly promotes 3T3-L1 adipogenesis through the PPARγ/C/EBPα program rather than the SREBP-1c lipogenic pathway. At sub-cytotoxic concentrations, curcumin reversed PFDA-induced upregulation of Pparg, Cebpa, and Fasn and reduced lipid accumulation by up to 68.3%. PFDA and curcumin interacted antagonistically on cell viability; however, curcumin fully retained its antiadipogenic activity.
What is the implication of the main finding?
Curcumin is a candidate dietary countermeasure against PFAS-driven metabolic disruption; moreover, this endpoint-specific interaction shows that a chemical interaction defined at one biological endpoint does not predict its outcome at another—an important caution for mixture toxicology.

Abstract

(1) Background: Perfluorodecanoic acid (PFDA), a persistent perfluoroalkyl obesogen, promotes adipogenesis, yet whether its effects can be pharmacologically opposed remains unknown. (2) Methods: We examined the interaction between PFDA (50, 75 μM) and the dietary polyphenol curcumin (20, 30 μM) throughout the 8-day 3T3-L1 preadipocyte differentiation protocol, using cell-viability (WST-1) assays with a two-factor interaction analysis, Oil Red O lipid quantification and mRNA profiling of Pparg, Cebpa, Srebf1, and Fasn. (3) Results: PFDA alone increased lipid accumulation and upregulated Pparg, Cebpa, and Fasn, whereas Srebf1 was induced only weakly and only at the higher dose, a pattern compatible with preferential engagement of the PPARγ/C/EBPα program over the SREBP-1c lipogenic pathway at the mRNA level, although the transcripts were not formally compared and no protein-level data were obtained. At two sub-cytotoxic concentrations, curcumin preserved potent antiadipogenic activity, reducing lipid accumulation by up to 67.3% and reversing PFDA-induced gene upregulation. At the viability endpoint the two compounds acted independently: curcumin significantly reduced viability and PFDA significantly increased it, with no statistically detectable interaction between them (two-way ANOVA, interaction p = 0.85). (4) Conclusions: This dissociation shows that a chemical interaction defined at one biological endpoint does not predict its outcome at another, a principle with broad implications for mixture toxicology—and it establishes curcumin as a candidate dietary intervention that intercepts an obesogen’s transcriptional program against environmentally driven metabolic disruption.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.